Zeomedix, Inc. is a start-up operating in the Pharmaceutical and Medicine Manufacturing Companies industry to develop advanced wound healing products for chronic wounds (diabetic foot ulcers, venous leg ulcers) and acute wounds (blast wounds, burns). The company now has four employees and funded contract research and animal trials at Drexel University.
